Cannabis Is Booming: Here’s the Top Pot Stock to Buy Today

I’ve been pounding the table for quite some time on Curaleaf (TSXV:CURA) as a top TSX pot stock. Indeed, this is the only Canada-listed cannabis company I would encourage investors to consider right now. The fact is, the Canadian cannabis sector is filled with a variety of options for investors right now. There’s a lot of noise in cannabis investing these days.…

Read More

PAOG Targets $18 Billion Anxiety And Depression Treatment Market

Sandusky, Ohio–(Newsfile Corp. – February 11, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s recently announced CBD nutraceutical development expansion will target the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025.The company recently announced plans to produce a variety of nutraceuticals for additional applications beyond the current focus on…

Read More

PAOG Plans To Add CBD Nutraceutical Revenue In 2021 To Cannabis Cultivation Revenue

Sandusky, Ohio–(Newsfile Corp. – February 10, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced the company plans to add revenue this year in 2021 from its developing CBD nutraceutical business to currently anticipated revenue from its cannabis cultivation business revenue.PAOG recently announced that it anticipated reporting approximately $50,000 in revenue in Q4 2020 from its cannabis cultivation business…

Read More

PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule

PAO Group, Inc. (USOTC: PAOG) today confirmed plans to publish a multimedia presentation next week on the company’s strategy to expand its nutraceutical product reach. The company added today that the presentation will also include details on the company’s ongoing CBD pharmaceutical developments. Source: Kaly PAOG Confirms CBD Pharmaceutical And Nutraceutical Product Development Presentation Schedule Kaly

Read More

Don’t Forget Pot Stocks! 1 High-Upside Investment for 2021

Pot stocks raged in 2018. Many businesses exploded in value several times over. Then the 2019 bear market erased nearly all the gains. By 2020, the COVID-19 crisis forced many to forget the industry altogether. Now is the perfect time to strike. Pot stocks will rise again When Canada legalized recreational marijuana nationwide, the market went bananas. Within months, every…

Read More

Cannabis Is Soaring! Curaleaf Stock’s Rise Is Only Just Getting Started…

The cannabis sector is absolutely red hot right now. Year to date, this sector is up nearly 70%, according to Horizons Medical Marijuana Life Sciences ETF, a basket of publicly traded cannabis companies. In the cannabis sector, I think Curaleaf (TSXV:CURA) provides the best risk/reward tradeoff for investors right now. In this article, I’m going to highlight why this stock tops…

Read More

PAOG To Extend CBD Nutraceuticals Reach Into $3.8 Billion Market

PAO Group, Inc. (USOTC: PAOG) today revealed plans to expand its nutraceutical product reach. The company plans to produce nutraceuticals for additional applications beyond the current focus on care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD). Source: Kaly PAOG To Extend CBD Nutraceuticals Reach Into .8 Billion Market Kaly

Read More

PAOG Confirms CBD Nutraceutical Development and Distribution Partners

Sandusky, Ohio–(Newsfile Corp. – February 2, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today confirmed its plans to develop and distribute cannabis nutraceuticals with Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) as partners.PAOG recently engaged with the Puerto Rico Consortium for Clinical Investigation (PRCCI) to assist PAOG with developing its proprietary…

Read More